# Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

> **NCT06531876** · — · COMPLETED · sponsor: **Beacon Biosignals** · enrollment: 78 (actual)

## Conditions studied

- Narcolepsy Type 1
- Hypersomnia
- Sleep Disorder

## Interventions

- **DEVICE:** Dreem 3S recording

## Key facts

- **NCT ID:** NCT06531876
- **Lead sponsor:** Beacon Biosignals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-01
- **Primary completion:** 2026-02-27
- **Final completion:** 2026-03-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06531876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06531876, "Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06531876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*